27 March 2017
Read this Ganjapreneur report on the scheduling decision
DEA Approves Synthetic Cannabis Medication by Anti-Cannabis Pharmaceutical Giant
Also see a report in Inquisitr
27 March 2017
Read this Ganjapreneur report on the scheduling decision
DEA Approves Synthetic Cannabis Medication by Anti-Cannabis Pharmaceutical Giant
Also see a report in Inquisitr